Results 1 to 10 of about 1,097,723 (197)
Some of the next articles are maybe not open access.

Endothelial Receptor Tyrosine Kinases Involved in Angiogenesis.

Journal of Cell Biology, 1995
Kari Alitalo
exaly  

Receptor Tyrosine Kinase Fusions and BRAF Kinase Fusions Are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors

Journal of Thoracic Oncology, 2018
Sai-Hong Ignatius Ou   +2 more
exaly  

The Evolving Field of Tyrosine Kinase Inhibitors in the Treatment of Endocrine Tumors

Endocrine Reviews, 2010
Libero Santarpia, Robert F Gagel
exaly  

Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm?

Trends in Endocrinology and Metabolism, 2015
Athanasios Fountas   +1 more
exaly  

Tyrosine Kinases as Targets in Cancer Therapy – Successes and Failures

Expert Opinion on Therapeutic Targets, 2003
Peter Traxler
exaly  

The Discovery of Receptor Tyrosine Kinases: Targets for Cancer Therapy

Nature Reviews Cancer, 2004
Oliver M Fischer   +2 more
exaly  

TYROSINE KINASE INHIBITORS AND INTERFERON

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
The use of interferon-a (INF) in chronic myeloid leukemia, when it started in the 80s, was considered as a breakthrough in the therapy of this disease; INF administered alone or in combination with aracytine was the standard choice for treatment for
Maria Dimou, Panagiotis Panagiotidis
doaj   +4 more sources

Home - About - Disclaimer - Privacy